US House Caucus Letter for Lyme/TBD Appropriations
The House Lyme Caucus members sent this letter to the House Appropriations Committee for inclusion in the 2020 Labor HHS Appropriations.
Congressional Activity
This section contains activity which Members of Congress or Congressional Committees or Caucuses are undertaking relative to tick-borne diseases.
Lyme & Tick-Borne Diseases Congressional Town Meeting
The Lyme & Tick-Borne Diseases Congressional Town Meeting will be held Wednesday, May 29, 2019 from 6:45pm-930pm at the Wall Township Municipal Building Community Room, 2700 Allaire Rd, Wall Township, NJ. The town meeting is sponsored by US Congressman Christopher H. Smith. Hear from nationally-recognized Lyme disease experts about current efforts to combat Lyme and Tick-Borne diseases, updates on diagnosis and treatment, and how to protect yourself and your family, and more. LDA president, Pat Smith, will join US Congressman, Christopher H. Smith; CDC, Deputy Director, Division of Vector-Borne Diseases, Ben Beard, PhD; and Richard Horowitz, MD as speakers at the meeting […]
Congressman Chris Smith: Lyme & TBD Testimony
March 27, 2019 House Appropriations Committee Labor, Health and Human Services, Education Member Day Hearing 1:00:30 to 1:02:20 (Lyme & TBD Discussion) Congressman Smith (NJ) testifies about working with Pat Smith and the Lyme community since 1992, pushing for an advisory committee since 1998, how language finally got put into 21st century cures act and the first […]
Congressmen Back Sen. Lyme Language
The national non-profit Lyme Disease Association (LDA) is pleased to announce that a letter led by Congressman Bill Shuster (R-PA) along with 23 other members of Congress was sent to the Senate HELP Committee Chair, Senator Lamar Alexander, and Ranking Member, Patty Murray, requesting their support for Lyme disease provisions found in the 21st Century […]
LDA Provides Input Into US House 21st Century Cures Initiative
The Lyme Disease Association, Inc. (LDA) submitted input into the US House of Representatives Energy & Commerce 21st Century Cures Initiative which will reform a number of areas in healthcare. E & C sought public input during their development process. Click Here for LDA Letter to Energy & Commerce Committee
Schumer to FDA: Fix Doxy Problem
US Senator Charles E. (Chuck) Schumer (NY) held a press conference at Konsico Dam Park in Valhalla, NY on August 12, 2014, to expose the issues surrounding the shortage and price hikes which have affected doxycycline for the past 21 months. At the conference, the Senator said, “We … must make sure that the FDA […]
Blumenthal Chairs Senate Lyme Hearing
On Thursday, August 30th, Senator Richard Blumenthal (CT) will host a U.S. Senate field hearing on the federal response to Lyme disease. “It is good news that the Senate is holding a hearing on Lyme. A more in-depth understanding of the issues will enable the government to develop a comprehensive plan on Lyme disease, especially […]
Congressman Chris Smith Reports Home
Click here for articles that appeared in Congressman Smith’s newsletter to his constituents in August 2012 regarding July 17th Lyme disease hearing in DC. Click here for articles that appeared in Congressman Smith’s newsletter to his constituents in August 2012 regarding July 17th Lyme disease hearing in DC. Congressman Christopher Smith (NJ) (4th L) Chair, Global Health & […]
DC Lyme Hearing: View & Take Action
The 2 hour July 17, 2012 Congressional hearing, Global Challenges in Diagnosing and Managing Lyme Disease – Closing Knowledge Gaps, was held by the Africa, Global Health and Human Rights Subcommittee on July 17, 2012 in Washington, DC. Significance of Hearing & Links to : The significance of the hearing is that it is the […]
Congress:Remove Stale Lyme Guidelines
Sign Petition Today January 21, 2012- Congressman Christopher Smith (NJ) with co-signers Congressmen Gibson (NY), and Wolf (VA) recently sent a letter to the National Guideline Clearing House (NGC), Agency for Healthcare Review & Quality (AHRQ) requesting the removal of the highly controversial Infectious Diseases Society of America’s (IDSA) Lyme Disease Treatment Guidelines from the […]
1 2